CABA vs MAR · $143.9M cap vs P/E 32, rev $26.19B
Cabaletta Bio Inc (CABA) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
Cabaletta Bio Inc (CABA) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
CABA does not have a complete income-statement cache yet.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
CABA currently screens at market cap $143.9M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the CABA and MAR stock pages for the full models.
Not investment advice.